ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 251 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $318,000 | -32.2% | 45,100 | -5.6% | 0.00% | 0.0% |
| Q4 2019 | $469,000 | -11.7% | 47,800 | -1.2% | 0.00% | -20.0% |
| Q3 2019 | $531,000 | -7.3% | 48,400 | -1.8% | 0.01% | 0.0% |
| Q2 2019 | $573,000 | -1.7% | 49,300 | -19.3% | 0.01% | 0.0% |
| Q1 2019 | $583,000 | -3.0% | 61,100 | -1.9% | 0.01% | 0.0% |
| Q4 2018 | $601,000 | -34.7% | 62,300 | -3.6% | 0.01% | -28.6% |
| Q3 2018 | $921,000 | +17.2% | 64,600 | -1.4% | 0.01% | +16.7% |
| Q2 2018 | $786,000 | -3.4% | 65,500 | -0.6% | 0.01% | -14.3% |
| Q1 2018 | $814,000 | -13.8% | 65,900 | +1.5% | 0.01% | 0.0% |
| Q4 2017 | $944,000 | -2.3% | 64,900 | -4.4% | 0.01% | -12.5% |
| Q3 2017 | $966,000 | +1.3% | 67,900 | -9.2% | 0.01% | +14.3% |
| Q2 2017 | $954,000 | +2.7% | 74,800 | +2.0% | 0.01% | 0.0% |
| Q1 2017 | $929,000 | +22.1% | 73,300 | -1.6% | 0.01% | +16.7% |
| Q4 2016 | $761,000 | -23.1% | 74,500 | -0.8% | 0.01% | -25.0% |
| Q3 2016 | $989,000 | +3.7% | 75,100 | 0.0% | 0.01% | +14.3% |
| Q2 2016 | $954,000 | -4.5% | 75,100 | -0.7% | 0.01% | -12.5% |
| Q1 2016 | $999,000 | -13.1% | 75,600 | +1.2% | 0.01% | -11.1% |
| Q4 2015 | $1,149,000 | +9.2% | 74,700 | -11.9% | 0.01% | +12.5% |
| Q3 2015 | $1,052,000 | -0.8% | 84,800 | +9.4% | 0.01% | +14.3% |
| Q2 2015 | $1,060,000 | +15.2% | 77,500 | +0.8% | 0.01% | +16.7% |
| Q1 2015 | $920,000 | -10.6% | 76,900 | -4.6% | 0.01% | -14.3% |
| Q4 2014 | $1,029,000 | -4.6% | 80,600 | +0.2% | 0.01% | 0.0% |
| Q3 2014 | $1,079,000 | -10.8% | 80,400 | +6.8% | 0.01% | -12.5% |
| Q2 2014 | $1,209,000 | -10.6% | 75,300 | +0.4% | 0.01% | -20.0% |
| Q1 2014 | $1,352,000 | +17.6% | 75,000 | +0.8% | 0.01% | +11.1% |
| Q4 2013 | $1,150,000 | +4.8% | 74,400 | +0.8% | 0.01% | -10.0% |
| Q3 2013 | $1,097,000 | +3.9% | 73,800 | -9.6% | 0.01% | 0.0% |
| Q2 2013 | $1,056,000 | – | 81,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |